Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

Status unconfirmed

Conditions studied: Kidney Transplant Rejection

In brief

Prospective Observational Multicenter Cohort. External validation of donor derived cell free DNA in Renal Transplantation. Assessing performance of dd-cfDNA as a surveillance tool and its association with clinical outcomes. Outcomes include formation of de-novo DSA, eGFR decline, performance of AlloSure dd-cfDNA in Allograft rejection.

Key facts

Study ID

NCT04566055

Run by

CareDx

People needed

1000

Starts

2019-03-01

Expected to finish

2020-10-01

Last updated by the study team

2020-10-05

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Renal transplant patients

Where it is running

• University of Colorado Hospital — Aurora, Colorado, United States
• Tampa General Hosptial — Tampa, Florida, United States
• University of Maryland — Baltimore, Maryland, United States
• University of Minnesota Medical Center — Minneapolis, Minnesota, United States
• Washington University — St Louis, Missouri, United States
• Memorial Hermann Hosptial — Houston, Texas, United States
• Intermountain Medical Center — Murray, Utah, United States
• Virginia Commonwealth University — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.